Cenexel CNS — Garden Grove, California

Cenexel CNS is a clinical research site located in Garden Grove, California, United States 92845.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Cenexel CNS has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Bipolar Disorder, Schizophrenia, Major Depressive Disorder.

Sponsors: Biohaven Therapeutics Ltd., Spinogenix, Sirtsei Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Garden Grove

Browse all research sites in California · View every site in Garden Grove

• Collaborative NeuroScience Network
• Research Site
• Collaborative Neuroscience Research
• National Institute of Clinical Research
• GSK Investigational Site
• Paragon Rx Clinical
• SC Clinical Research
• Alkermes Investigational Site
• CNS Network
• Pfizer Investigational Site
• Orange County Ophthalmology Medical Group
• Clinical Site

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cenexel CNS?

Cenexel CNS has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cenexel CNS conducted?

Cenexel CNS has 5 clinical trials on record, with 1 currently active. Their work covers Bipolar Disorder, Schizophrenia, Major Depressive Disorder.

Is Cenexel CNS accredited by Crixeo Clinical Trials?

Cenexel CNS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cenexel CNS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.